NCT03806309 OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03794635 An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT03785249 Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1 Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03758781 IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT03757858 Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases Status COMPLETED Phase PHASE1/PHASE2
NCT03749850 Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer Status UNKNOWN Phase PHASE1
NCT03714958 Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type Status COMPLETED Phase PHASE1
NCT03712566 Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03693014 A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03691714 Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03689192 Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT03671720 Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden Status WITHDRAWN Phase EARLY_PHASE1
NCT03658785 Immunotherapy for the Treatment of Advanced Solid Tumor Status RECRUITING Phase PHASE1/PHASE2
NCT03637335 Comparing Palliative Radiotherapy With or Without Carboplatin Status TERMINATED Phase PHASE3
NCT03585673 Docetaxel-polymeric Micelles(PM) and Oxaliplatin for Esophageal Carcinoma Status UNKNOWN Phase PHASE2
NCT03570619 Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations Status COMPLETED Phase PHASE2
NCT03569241 PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE2